CSPC Pharmaceutical Group Limited

Research CSPC Pharmaceutical Group Limited (1093.HK) on Bullrun: market cap HKD 79.50B, P/E 17.9, dividend yield 4.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker1093.HK
CountryHong Kong
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyHKD
Market capHKD 79.50B
P/E17.9
Dividend yield4.2%
Financial periodFY2025
RevenueHKD 26.01B
Revenue growth-10.4%
Net incomeHKD 3.88B
Free cash flowHKD 3.55B
Gross margin65.6%

Valuation Snapshot

latest market cap is HKD 79.50B; P/E is 17.9; dividend yield is 4.2%.

About CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment;

Frequently asked questions

What is CSPC Pharmaceutical Group Limited's market cap?

CSPC Pharmaceutical Group Limited's market capitalization is HKD 79.50B.

What is CSPC Pharmaceutical Group Limited's P/E ratio?

CSPC Pharmaceutical Group Limited's price-to-earnings (P/E) ratio is 17.9.

Does CSPC Pharmaceutical Group Limited pay a dividend?

CSPC Pharmaceutical Group Limited has a dividend yield of 4.2%.